what does patient focused drug development look like for rare diseases sd 480p
Published 9 months ago • 63 plays • Length 59:23Download video MP4
Download video MP3
Similar videos
-
3:37
what is patient-focused drug development (pfdd)?
-
3:00
how will rdca-dap® support patient-focused drug development?
-
1:24:07
regulatory pathway and applications in drug development for rare diseases
-
2:33
rare disease patient voice: david fajgenbaum
-
1:59
jane larkindale - what is c-path doing that is unique in drug development for rare disease?
-
3:14
blood-brain barrier model to test drugs for brain diseases
-
4:21
pediatric movement disorders: guidance for parents & physicians
-
14:13
psychodermatology: more than skin deep | linda papadopoulos | tedxuniversityofmanchester
-
4:07
what is exciting to you about taking on this ambitious project?
-
22:01
optimization of clinical trial design for rare disease through modeling: example in duchenne’s
-
2:27
jane larkindale - why are c-path drug development tools important in rare disease drug development?
-
1:02:02
2022 externally-led patient-focused drug development - informational meeting
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
4:17
rdca-dap: shortening the timeline for developing new treatments for rare diseases
-
2:06
rare disease patient voice: kelly barendt
-
1:51
rare disease patient voice: justin moy
-
0:59
patient focused drug development and the fda
-
2:10
rare disease patient voice: kurt michels
-
1:59
rare disease patient voice: joanna johnson
-
3:27
what does the fda hope to achieve through developing the rare disease cures accelerator?
-
3:44
rare disease challenges in each step of the drug development process
-
57:08
industry perspective on drug development in rare diseases